Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01409538 · ClinicalTrials.gov registry record · Phase 1
Brain Imaging and Pain: Analysis of Placebo Analgesia
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 140
- Enrollment target
NCT01409538: Completed Phase 1 study, sponsored by University of Florida.
NCT01409538 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 140 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (133% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01409538, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 140 participants
- Enrollment target
Study Summary
This study examines the brain activation associated with placebo pain reduction.
Primary Outcome
This outcomes represents the neural network underpinnings of the placebo analgesic response. It is the result of a network analysis using structural equation modeling of fMRI determined brain activations.
Interventions
- OTHER Control condition
- OTHER Placebo Instructions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
What the finished NCT01409538 record still lists
NCT01409538 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (133% higher).
The record links to 0 conditions, and to 2 interventions - of which Control condition is the first listed.
NCT01409538 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01409538 about?
NCT01409538 is a clinical study titled "Brain Imaging and Pain: Analysis of Placebo Analgesia". This study examines the brain activation associated with placebo pain reduction.
What is the current status of trial NCT01409538?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2010-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01409538?
The interventions under investigation include: Control condition (OTHER), Placebo Instructions (OTHER).
Who is sponsoring clinical trial NCT01409538?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01409538's enrollment target sits among peer trials
140 402nd of 2000 higher than 1,583 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia